NCT05406674View on ClinicalTrials.gov

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
FIGO Stage III Ovarian CancerPeritoneal CancerFallopian Tube Carcinoma
Interventions
DRUG

Cisplatin 100 mg/m2

Cisplatin 100 mg/m2 milligram(s)/square meter

DRUG

Cisplatin 40 mg/l

Cisplatin 40 mg/I milligram(s)/litre

Trial Locations (2)

1066 CX

Antoni van Leeuwenhoek (NKI-AVL), Amsterdam

Unknown

UMCU, Utrecht

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER